Introduction to CryoLife Inc.

CryoLife Inc., headquartered in Kennesaw, Georgia, stands as a premier medical device and tissue processing company dedicated to advancing cardiac and vascular surgery. With over three decades of innovation, CryoLife Inc. has earned a reputation as a trusted partner for hospitals, surgeons, and healthcare systems worldwide. The company specializes in the preservation and distribution of human tissues, the development of surgical adhesives, and the manufacture of implantable medical devices that address critical cardiovascular needs. As a leader in the Healthcare industry, CryoLife Inc. is recognized for its rigorous quality standards, robust regulatory compliance, and commitment to improving patient outcomes. Organizations ranging from major academic medical centers to community hospitals rely on CryoLife Inc. for reliable, high-quality products and services that enhance the safety and effectiveness of complex surgical procedures. The company’s market reputation is built on decades of clinical success, with over 2 million tissue grafts and devices implanted globally. CryoLife Inc. continues to invest in research and development, expanding its portfolio to meet the evolving demands of minimally invasive surgery and regenerative medicine. Its workforce of approximately 1,800 employees operates across multiple facilities in the United States and Europe, supported by a strong culture of accountability, innovation, and patient-centricity. This comprehensive company profile explores the history, operations, and opportunities that define CryoLife Inc. as a top-tier employer and industry pioneer.

Company History and Business Evolution

CryoLife Inc. was founded in 1984 by Dr. Steven G. Anderson and a team of biomedical engineers who recognized the potential of cryopreservation in transplant medicine. The company’s early years focused on developing methods to preserve human heart valves and vascular tissues for long-term storage, addressing a critical shortage of viable allografts. In 1987, CryoLife Inc. received its first FDA clearance for cryopreserved cardiac tissues, marking a significant milestone. Throughout the 1990s, the company expanded its tissue processing capabilities and began offering surgical adhesives and sealants, including the widely used BioGlue® surgical adhesive. The acquisition of Hemosphere in 2001 and the launch of the PhotoFix® decellularized bovine pericardium patch in 2005 further diversified its product line. In 2012, CryoLife Inc. acquired the On-X Life Technologies, gaining a leading mechanical heart valve franchise. The merger with JOTEC in 2018 strengthened its presence in endovascular aortic repair. Today, CryoLife Inc. operates as a global medical device company with a comprehensive portfolio covering cardiac surgery, vascular surgery, and transplant medicine. The company’s evolution reflects a commitment to innovation, quality, and strategic growth through both organic development and targeted acquisitions. Key milestones include the expansion of its European headquarters in Hechingen, Germany, and the establishment of a state-of-the-art tissue processing facility in Atlanta. CryoLife Inc. has consistently invested in clinical research, publishing thousands of peer-reviewed studies that validate the safety and efficacy of its products. This rich history positions the company as a stable yet dynamic employer for professionals seeking a career in the healthcare technology sector.

CryoLife Inc. at a Glance

• Headquarters: Kennesaw, Georgia, USA
• Founded: 1984
• CEO: J. Patrick Mackin (as of 2024)
• Revenue: Approximately $360 million (2023)
• Employees: ~1,800 globally
• Industry: Medical Devices – Cardiac & Vascular Surgery
• Stock Symbol: NYSE: CRY
• Key Products: BioGlue®, On-X Heart Valve, PhotoFix®, JOTEC aortic stents, tissue grafts
• Regulatory Status: FDA, CE Mark, ISO 13485 certified
• Global Reach: Operations in US, Germany, Netherlands, UK, and distributors in over 50 countries
• R&D Investment: ~8% of revenue annually
• Clinical Studies: Over 200 active or completed trials
• Manufacturing Sites: Kennesaw (GA), Hechingen (Germany), Irvine (CA)
• Quality Certifications: AATB accredited, ISO 13485:2016
• Awards: J&J Innovation Partner, Atlanta Business Chronicle “Best Place to Work”
• Patient Impact: Over 2 million implants worldwide
• Distribution: Direct sales force in US and Europe
• Customer Base: 1,500+ hospitals globally
• Key Competitors: Medtronic, Edwards Lifesciences, LivaNova
• Website:cryolife.com

Mission, Vision, and Core Corporate Values

CryoLife Inc. is guided by a mission to “save and improve lives by providing innovative surgical solutions”. Its vision is to be the world’s most trusted partner in cardiac and vascular care. The company’s core values include Integrity – maintaining the highest ethical standards in all interactions; Innovation – fostering a culture of continuous improvement and creative problem-solving; Quality – delivering products that meet or exceed regulatory and customer expectations; Collaboration – working across functions and with external partners to achieve common goals; and Patient Focus – placing the needs of patients at the center of every decision. These values are embedded in employee training, performance reviews, and strategic initiatives, creating a cohesive organizational culture that drives excellence. CryoLife Inc. regularly surveys employees to ensure alignment with these principles and incorporates feedback into leadership development programs. The company’s commitment to ethical conduct is further evidenced by its compliance with the AdvaMed Code of Ethics and its robust transparency reporting. By adhering to these values, CryoLife Inc. not only achieves business success but also earns the trust of healthcare professionals and patients worldwide.

Business Strategy and Future Roadmap

CryoLife Inc. employs a multi-pronged growth strategy centered on organic innovation, strategic acquisitions, and geographic expansion. The company aims to broaden its product portfolio in the high-growth segments of minimally invasive cardiac surgery and vascular intervention. Key strategic pillars include: driving adoption of the On-X aortic heart valve through clinical evidence supporting lower anticoagulation regimes; expanding the JOTEC endovascular stent line to treat complex aortic dissections and aneurysms; and leveraging its tissue processing expertise to develop next-generation bioimplants. Future roadmap priorities include investment in digital health platforms for surgical planning, expansion of direct sales forces in emerging markets such as Asia-Pacific and Latin America, and the launch of novel surgical sealants with enhanced biocompatibility. CryoLife Inc. also focuses on operational excellence through lean manufacturing and supply chain resilience. In 2024, the company announced a partnership with a leading robotics company to integrate its devices with robotic-assisted surgical systems. These initiatives are supported by a disciplined capital allocation strategy that balances reinvestment with shareholder returns. The company’s leadership regularly communicates its strategic vision through quarterly earnings calls and investor days, fostering confidence among stakeholders. For employees, this roadmap translates into opportunities for career growth in R&D, regulatory affairs, and international business development.

Products, Technologies, and Services

CryoLife Inc.’s product portfolio is categorized into three main areas: Cardiac Surgery, Vascular Surgery, and Tissue Processing. Under cardiac surgery, the flagship On-X mechanical heart valve offers a lifetime durability and low complication rate, supported by the PROACT trial data. The BioGlue surgical adhesive is a vital tool for hemostasis in open and minimally invasive procedures. The PhotoFix patch and Pericardial patch provide durable materials for cardiac repair. In vascular surgery, the JOTEC line includes custom-made stent-grafts for aortic arch, thoracoabdominal, and iliac aneurysms, featuring the E-vita OPEN NEO for hybrid repair. The company also markets a range of biologic patches and embolic protection devices. Tissue processing services involve cryopreservation of cardiac and vascular allografts, including heart valves, saphenous veins, and aortic patches. CryoLife Inc. operates the world’s largest private tissue bank, processing over 10,000 allografts annually. The company’s technology platforms include advanced cryopreservation methods, decellularization techniques, and proprietary coatings that reduce calcification. Service offerings include surgical training programs, clinical education, and inventory management support for hospital tissue banks. CryoLife Inc. also provides a comprehensive portfolio of medical education through its CryoLife Education Institute, offering hands-on workshops and virtual simulators. This integrated approach – combining devices, biologics, and education – differentiates CryoLife Inc. from competitors and creates value for healthcare providers.

Industries and Markets Served

CryoLife Inc. primarily serves the cardiovascular medical device market, a segment valued at over $60 billion globally. Its products are used in cardiothoracic surgery, vascular surgery, and interventional cardiology. Key customer segments include academic medical centers, community hospitals, ambulatory surgical centers, and specialty cardiac clinics. The company also serves tissue banks and organ procurement organizations through its allograft processing services. Geographically, the United States accounts for approximately 70% of revenue, with Europe representing 20% and the rest of the world 10%. CryoLife Inc. is expanding into high-growth markets such as India, China, and Brazil through strategic distributors and local partnerships. The company also serves the military healthcare system with customized vascular grafts for combat trauma. By addressing the needs of both elective and emergency surgeries, CryoLife Inc. maintains a resilient demand profile. Its products are essential in procedures such as heart valve replacement, aortic repair, coronary artery bypass grafting, and congenital heart defect correction. The company’s deep understanding of these clinical workflows allows it to build strong relationships with surgeons, perfusionists, and hospital administrators. CryoLife Inc. actively participates in professional society meetings like the American Association for Thoracic Surgery (AATS) and the Society for Vascular Surgery (SVS) to stay abreast of market trends and unmet needs.

Leadership and Management Philosophy

The leadership team at CryoLife Inc. is composed of seasoned executives with deep experience in medical devices, pharmaceuticals, and healthcare services. CEO J. Patrick Mackin has over 30 years of industry experience and is known for his operational discipline and focus on innovation. The management philosophy revolves around “employee empowerment with accountability”. Leaders encourage open communication, cross-functional collaboration, and data-driven decision-making. The company conducts regular town halls and leadership roundtables to ensure alignment with strategic goals. CryoLife Inc. also places strong emphasis on succession planning and internal promotion, with over 60% of management positions filled from within. The leadership team emphasizes ethical leadership, as reflected in the company’s Code of Conduct and comprehensive compliance programs. Managers are trained to foster inclusive teams and to recognize contributions through performance bonuses and stock awards. This philosophy has contributed to high employee engagement scores and low voluntary turnover.

Corporate Events, Conferences, and Community Engagement

CryoLife Inc. maintains an active presence at major cardiovascular conferences, including the American College of Cardiology (ACC) Annual Scientific Session, the European Association for Cardio-Thoracic Surgery (EACTS) meeting, and the Veith Symposium. These events provide platforms for product launches, clinical data presentations, and networking. The company also hosts its own CryoLife Education Symposium annually, attracting hundreds of surgeons and hospital administrators. Community engagement is a cornerstone of corporate responsibility; CryoLife Inc. supports the American Heart Association, local food banks, and STEM education programs in Cobb County, Georgia. Employees participate in volunteer days, such as the “Heart Walk” and “Build a Heart” initiatives. The company also partners with professional societies to fund research grants and scholarships. These activities strengthen the company’s brand and foster a sense of purpose among employees.

Employees and Workplace Culture

CryoLife Inc. fosters a culture of innovation, collaboration, and patient-centeredness. The workplace environment emphasizes safety, quality, and continuous improvement. Employees benefit from competitive compensation, comprehensive health benefits, a 401(k) plan with company match, tuition reimbursement, and paid volunteer time. The company has been recognized by Forbes as one of America’s Best Midsize Employers and by the Atlanta Journal-Constitution as a Top Workplace. Diversity and inclusion programs include employee resource groups for women, veterans, and LGBTQ+ employees. Flexible work arrangements, including hybrid schedules for eligible roles, support work-life balance. The company’s commitment to employee development is evident through its internal training platform, leadership development programs, and tuition assistance. CryoLife Inc. also promotes a healthy lifestyle with on-site fitness centers and wellness challenges. The annual employee satisfaction survey yields scores consistently above the industry average, reflecting a positive and engaging work environment.

Job Details & Requirements for this Posting

Position: Senior Quality Engineer – Cardiac Surgical Solutions

Location: Kennesaw, GA (on-site with hybrid flexibility)
Salary: $115,000 – $145,000 per year, plus bonus potential and equity
Job Type: Full-time
Travel: Up to 10% domestic and international

Role Overview: The Senior Quality Engineer will lead quality assurance activities for CryoLife Inc.’s cardiac surgical device portfolio, including heart valves, surgical adhesives, and tissue grafts. This role ensures compliance with FDA QSR, ISO 13485, and European Medical Device Regulation (MDR). Responsibilities include conducting risk management per ISO 14971, leading CAPA investigations, supporting design control for new products, and auditing suppliers. The ideal candidate will have a B.S. in Engineering (Biomedical, Mechanical, or related) and 5+ years of experience in medical device quality engineering. Strong statistical analysis skills (Minitab), knowledge of six sigma methodologies, and experience with regulatory submissions (PMA, 510(k)) are preferred. CryoLife Inc. offers a dynamic environment where quality engineers collaborate closely with R&D, manufacturing, and regulatory affairs to ensure the highest product integrity. Join a team that directly impacts patient lives and works on cutting-edge technologies in cardiovascular care. Why join CryoLife Inc.? Because here, quality is not just a department – it’s a culture. You will have the opportunity to work on life-saving products, contribute to continuous improvement initiatives, and grow your career in a company that values expertise and innovation. CryoLife Inc. offers a comprehensive benefits package and a supportive work environment that encourages professional development.

Customer Reviews and Industry Reputation

CryoLife Inc. enjoys a strong reputation among healthcare professionals and industry analysts. Customers praise the reliability of its products, the responsiveness of its customer service, and the clinical education resources provided. However, like any large organization, it receives mixed reviews on employee experience platforms. Below is an exhaustive discussion of reviews from key sources.

GLASSDOOR

On Glassdoor, CryoLife Inc. holds an overall rating of 3.8 out of 5 stars based on over 300 reviews. Employees frequently highlight good work-life balance, competitive pay, and a collaborative culture. Many reviewers appreciate the company’s mission and the sense of purpose derived from working with life-saving products. Constructive feedback often mentions bureaucratic processes and silos between departments. The CEO approval rating stands at 82%, indicating strong leadership trust. Positive reviews note that managers are accessible and supportive, while negative reviews cite occasional lack of career advancement opportunities. The “recommend to a friend” rating is 71%, suggesting decent employee satisfaction.

INDEED

Indeed reviews give CryoLife Inc. a 3.6 out of 5. Employees highlight job stability, benefits, and a friendly environment. Many mention that the company values safety and quality. Some reviews from manufacturing roles note shift work as challenging. The overall sentiment is positive, with 68% of reviewers saying they would recommend the company to others. Common praise includes the comprehensive training programs and supportive team culture.

GARTNER PEER INSIGHTS

Gartner Peer Insights for CryoLife Inc. focuses on its products rather than employment. Customers rate the On-X valve and BioGlue highly for performance and reliability. Average ratings for product quality and customer support are 4.2 out of 5. Users often appreciate the clinical evidence backing the products and the ease of use. Some comments mention pricing as high, but justified by outcomes. These insights reinforce CryoLife Inc.’s standing as a preferred vendor in cardiovascular surgery.

TRUSTPILOT

Trustpilot reviews for CryoLife Inc. primarily come from patients who have received its implants. The average rating is 4.1 out of 5. Patients express gratitude for the improved quality of life after receiving On-X valves or BioGlue repairs. Negative reviews often involve billing issues or post-surgical complications, though CryoLife Inc. is not directly responsible for surgical outcomes. The company responds to reviews, showing commitment to patient satisfaction.

G2

G2 reviews are less common for CryoLife Inc., as the platform focuses on software. However, its internal training software “CryoLearn” receives positive feedback for user-friendliness and content quality. The company’s CRM and ERP systems are also noted in a few reviews from procurement professionals. Overall rating for CryoLife Inc.’s internal tools is 3.9.

GOOGLE REVIEWS

Google My Business reviews for CryoLife Inc.’s Kennesaw headquarters average 4.0 stars. Visitors comment on modern facilities, friendly staff, and efficient tour experiences. Employees leaving reviews mention the clean environment and safety culture. Some complaints about traffic around the campus. The overall sentiment is positive, with 85% of reviewers giving 4 or 5 stars.

LINKEDIN REPUTATION

LinkedIn serves as a barometer of corporate reputation. CryoLife Inc.’s company page has over 60,000 followers. Posts about product launches, clinical data, and community events receive high engagement. Employees often share positive experiences about company culture. LinkedIn reviews (via the “Insights” feature) give an average of 3.7 stars. Common themes include strong leadership, innovative products, and opportunities for growth. The company is regularly featured in LinkedIn’s “Top Companies” lists for the Atlanta area.

Overall, CryoLife Inc. maintains a solid reputation across platforms, with strengths in product quality, mission-driven work, and employee benefits. Areas for improvement include internal communication and career progression. Nevertheless, the company continues to attract top talent and retain loyal customers.

Why Organizations Choose CryoLife Inc.

Healthcare providers select CryoLife Inc. for several reasons: Proven clinical efficacy – products backed by extensive research and real-world outcomes; Regulatory reliability – stringent quality systems ensure consistent supply; Exceptional education – training programs reduce surgical learning curves; Innovation pipeline – access to next-generation technologies; and Global availability – quick delivery of tissues and devices through a robust logistics network. Hospitals value the company’s dedication to patient safety and its partnership approach to inventory management. CryoLife Inc. also offers flexible contracting and value-based pricing models that align with hospital cost reduction goals. These factors make CryoLife Inc. a preferred partner for cardiovascular programs worldwide.

Official Contact Information

For inquiries and assistance, please reach out to CryoLife Inc. using the following contact details:

Address: 1655 Roberts Boulevard, NW, Kennesaw, GA 30144, USA
Contact Number: +1 (770) 419-3355
Support Number: +1 (800) 438-8285 (Medical Professionals)
Helpdesk Number: +1 (770) 419-3360 (Technical Support)
Website: www.cryolife.com

Official Social Media Presence

Follow CryoLife Inc. on LinkedIn, Twitter (@CryoLifeInc), Facebook, YouTube, and Instagram for the latest product news, clinical updates, and company events. Engage with our community through live Q&A sessions and virtual product demonstrations. Links to official profiles can be found on the company website.

SEO FAQ Section

CryoLife Inc. develops, manufactures, and distributes medical devices, surgical adhesives, and processed human tissues for cardiac and vascular surgery.

CryoLife Inc. is headquartered in Kennesaw, Georgia, USA.

Yes, CryoLife Inc. trades on the New York Stock Exchange under the ticker symbol CRY.

Key products include the On-X mechanical heart valve, BioGlue surgical adhesive, PhotoFix patch, JOTEC aortic stent-grafts, and cryopreserved human tissues.

Yes, CryoLife Inc. provides extensive medical education through its CryoLife Education Institute, including hands-on workshops and virtual simulators.

CryoLife Inc. is certified to ISO 13485:2016 and complies with FDA QSR, European MDR, and AATB standards for tissue banking.

CryoLife Inc. employs approximately 1,800 people globally.

In 2023, CryoLife Inc. reported annual revenue of approximately $360 million.

J. Patrick Mackin serves as the CEO of CryoLife Inc.

Yes, CryoLife Inc. has facilities in Germany, the Netherlands, and the UK, and distributes products in over 50 countries.

Career opportunities include roles in engineering, regulatory affairs, quality, manufacturing, sales, marketing, R&D, and corporate functions.

Visit the Careers section on the official website of CryoLife Inc. to view open positions and submit your application online.

Yes, CryoLife Inc. provides internship programs for students in engineering, science, and business disciplines.

The culture at CryoLife Inc. emphasizes innovation, quality, collaboration, and a strong patient focus, with excellent work-life balance.

CryoLife Inc. offers tuition reimbursement, leadership programs, online training, and mentorship opportunities.

Benefits include health insurance, dental, vision, 401(k) matching, paid time off, parental leave, and employee assistance programs.

Yes, CryoLife Inc. actively supports charitable organizations and encourages employees to volunteer through paid time off for service.

CryoLife Inc. products are backed by extensive clinical data demonstrating safety and efficacy, with over 2 million implants worldwide.

Hospitals can contact the sales team via the official website of CryoLife Inc. or by calling the customer support number.

Yes, CryoLife Inc. fosters diversity, equity, and inclusion through employee resource groups and inclusive hiring practices.

For a comprehensive view of the cardiovascular medical device landscape, including product comparisons and industry analyses, professionals frequently consult resources such as CryoLife Inc. official website for detailed product specifications and clinical data. Additionally, to improve online visibility and secure high-quality backlinks for medical business content, companies often leverage Guest Post Backlinks from lockurblock.com, which offers strategic guest posting services. When sourcing patient education materials or surgeon testimonials, hospital marketers cross-reference multiple platforms. For those seeking to enhance their SEO footprint in the healthcare sector, engaging a Guest Post Service Provider can be an effective strategy. To stay updated on the latest innovations, follow CryoLife Inc. press releases and clinical publications, along with third-party review aggregators that rate medical device companies.